Middle East & Africa Lung Cancer Screening Market Forecast to 2030

According to the research team’ Research, the Middle East & Africa lung cancer screening market was valued at US$ 17.52 million in 2022 and is expected to reach US$ 30.11 million by 2030, registering a CAGR of 7.0% from 2022 to 2030. Rising lung cancer incidences is the critical factor attributed to the Middle East & Africa lung cancer screening market.
Lung cancer is among one of the main causes of mortality across the world. Lung cancer screening is a critical component of cancer prevention approaches. The prognosis of lung cancer patients is better when the disease is diagnosed early, so people at high risk of lung cancer are prompted to undergo routine checkups to detect the formation of cancerous growth in their lungs.

The socioeconomic conditions, healthcare infrastructure, and methods used to provide healthcare vary greatly throughout the Middle Eastern and African nations. The prevalence of lung cancer is extremely high in these nations and is expected to keep rising in the near future. Thus, the rising incidences of lung cancer are contributing to the initiation of lung cancer screening programs, which drive market growth.
On the contrary, high cost of lung cancer screening hampers the Middle East & Africa lung cancer screening market.

Based on cancer type, the Middle East & Africa lung cancer screening market is segmented into non–small cell lung cancer (NSCLC) and small cell lung cancer. The non–small cell lung cancer (NSCLC) segment held 82.5% share of Middle East & Africa lung cancer screening market in 2022, amassing US$ 14.46 million. It is projected to garner US$ 24.49 million by 2030 to expand at 6.8% CAGR during 2022–2030.

Based on technology, the Middle East & Africa lung cancer screening market is segmented into chest X-ray, low dose computed tomography (LDCT), liquid biopsy, and others. The chest X-ray segment held 45.7% share of Middle East & Africa lung cancer screening market in 2022, amassing US$ 8.00 million. It is projected to garner US$ 14.13 million by 2030 to expand at 7.4% CAGR during 2022–2030.

Based on age group, the Middle East & Africa lung cancer screening market is segmented into 50 and Older and Below 50. The 50 and older segment held 88.8% share of Middle East & Africa lung cancer screening market in 2022, amassing US$ 15.55 million. It is projected to garner US$ 26.55 million by 2030 to expand at 6.9% CAGR during 2022–2030.

Based on end user, the Middle East & Africa lung cancer screening market is segmented into hospitals, diagnostic centers, and others. The hospitals segment held 50.2% share of Middle East & Africa lung cancer screening market in 2022, amassing US$ 8.79 million. It is projected to garner US$ 14.64 million by 2030 to expand at 6.6% CAGR during 2022–2030.

Based on country, the Middle East & Africa lung cancer screening market has been categorized into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 42.3% share of Middle East & Africa lung cancer screening market in 2022. It was assessed at US$ 7.41 million in 2022 and is likely to hit US$ 12.38 million by 2030, exhibiting a CAGR of 6.6% during 2022–2030.
Key players operating in the Middle East & Africa lung cancer screening market are Nuance Communications Inc, GE HealthCare, Medtronic, Canon Inc, Koninklijke Philips NV, and Siemens AG, Inc among others.

1. Introduction
1.1 Study Scope
1.2 The Research Team Report Guidance
1.3 Market Segmentation
1.3.1 Middle East & Africa Lung Cancer Screening Market – by Technology
1.3.2 Middle East & Africa Lung Cancer Screening Market – by Cancer Type
1.3.3 Middle East & Africa Lung Cancer Screening Market – by Age Group
1.3.4 Middle East & Africa Lung Cancer Screening Market – by End User
1.3.5 Middle East & Africa Lung Cancer Screening Market – by Country
2. Middle East & Africa Lung Cancer Screening Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Lung Cancer Screening Market – Market Landscape
4.1 Overview
4.2 Middle East & Africa PEST Analysis
4.3 Expert’s Opinion
5. Middle East & Africa Lung Cancer Screening Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Lung Cancer Incidences
5.2 Market Restraints
5.2.1 Lack of Awareness regarding the Lung Cancer Screening:
5.3 Market Opportunities
5.3.1 Collaboration with Regional Hospitals and Clinics
5.4 Future Trends
5.4.1 Use of Cutting-Edge Technologies
5.5 Impact Analysis
6. Lung Cancer Screening Market – Middle East & Africa Market Analysis
6.1 Middle East & Africa Lung Cancer Screening Market Revenue Forecast and Analysis
7. Middle East & Africa Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type
7.1 Overview
7.2 Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
7.3 Non–Small Cell Lung Cancer (NSCLC)
7.3.1 Overview
7.3.2 Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)
7.4 Small Cell Lung Cancer
7.4.1 Overview
7.4.2 Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Lung Cancer Screening Market Analysis – by Technology
8.1 Overview
8.2 Low-Dose Computed Tomography (LDCT)
8.2.1 Overview
8.2.2 Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.3 Chest X-ray
8.3.1 Overview
8.3.2 Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.4 Liquid Biopsy
8.4.1 Overview
8.4.2 Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Lung Cancer Screening Market Analysis – by Age Group
9.1 Overview
9.2 & Older
9.2.1 Overview
9.2.2 & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Below 50
9.3.1 Overview
9.3.2 Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Lung Cancer Screening Market Analysis – by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Diagnostic Centers
10.3.1 Overview
10.3.2 Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis
11.1 Overview
11.1.1 Middle East & Africa: Lung Cancer Screening Market, by Key Country, 2020-2030 (%)
11.1.1.1 South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.1 Overview
11.1.1.1.2 South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.1.3 South Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.1.4 South Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.1.5 South Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.1.6 South Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.2 Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.1 Overview
11.1.1.2.2 Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.2.3 Saudi Arabia: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.2.4 Saudi Arabia: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.2.5 Saudi Arabia Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.2.6 Saudi Arabia: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.3 UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.1 Overview
11.1.1.3.2 UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.3.3 UAE: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.3.4 UAE: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.3.5 UAE Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.3.6 UAE: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
11.1.1.4 Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.1 Overview
11.1.1.4.2 Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
11.1.1.4.3 Rest of Middle East & Africa: Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)
11.1.1.4.4 Rest of Middle East & Africa: Lung Cancer Screening Market, by Technology, 2020-2030 (US$ Million)
11.1.1.4.5 Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)
11.1.1.4.6 Rest of Middle East & Africa: Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)
12. Lung Cancer Screening Market–Industry Landscape
12.1 Recent Growth Strategies
12.1.1 Overview
13. Company Profiles
13.1 Nuance Communications Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GE HealthCare
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medtronic
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Canon Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips NV
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
14. Appendix
14.1 About Research Team
14.2 Glossary of Terms

Table 1.             South Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 2.             South Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3.             South Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 4.             South Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5.             Saudi Arabia Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 6.             Saudi Arabia Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7.             Saudi Arabia Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 8.             Saudi Arabia Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9.             UAE Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 10.          UAE Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11.          UAE Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 12.          UAE Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13.          Rest of Middle East & Africa Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 2030 (US$ Million)
Table 14.          Rest of Middle East & Africa Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15.          Rest of Middle East & Africa Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)
Table 16.          Rest of Middle East & Africa Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17.          Recent Growth Strategies in the Lung Cancer Screening Market
Table 18.          Glossary of Terms

Figure 1.           Middle East & Africa Lung Cancer Screening Market Segmentation
Figure 2.           Middle East & Africa Lung Cancer Screening Market, by Country
Figure 3.           Middle East & Africa Lung Cancer Screening Market Overview
Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Middle East & Africa Lung Cancer  Screening Market
Figure 5.           Middle East & Africa Expected to Show Remarkable Growth During Forecast Period
Figure 6.           Middle East & Africa: PEST Analysis
Figure 7.           Experts’ Opinion
Figure 8.           Lung Cancer Screening Market Impact Analysis of Driver and Restraints
Figure 9.           Middle East & Africa Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030
Figure 10.        Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)
Figure 11.        Non–Small Cell Lung Cancer (NSCLC): Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12.        Small Cell Lung Cancer: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13.        Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)
Figure 14.        Low-Dose Computed Tomography (LDCT): Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 15.        Chest X-ray: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 16.        Liquid Biopsy: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 17.        Others: Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)
Figure 18.        Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)
Figure 19. & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21.        Lung Cancer Screening Market, by End User, 2022 & 2030 (%)
Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25.        Middle East & Africa: Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)
Figure 26.        Middle East & Africa: Lung Cancer Screening Market, by Country, 2022 & 2030 (%)
Figure 27.        South Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28.        Saudi Arabia: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29.        UAE: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30.        Rest of Middle East & Africa: Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)